Rationale: Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a
multicomponent disease with systemic consequences and effects on quality of life. Single …

Background Despite the availability of national and international guidelines, evidence suggests
that chronic obstructive pulmonary disease (COPD) treatment is not always prescribed …

Background Clinical characteristics of the international population with severe asthma are
unknown. Intercountry comparisons are hindered by variable data collection within regional …

Background In sub-Saharan Africa, little is known about the damage to respiratory health
caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic …

Background Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid
[ICS] plus long-acting β 2 -agonist bronchodilator [LABA] plus long-acting muscarinic …

Background Patterns of health-care use and comorbidities present in patients in the period
before diagnosis of chronic obstructive pulmonary disease (COPD) are unknown. We …

Rationale: Forty percent of households worldwide burn biomass fuels for energy, which may
be the most important contributor to household air pollution. Objectives: To examine the …

Background People with severe asthma experience significant respiratory symptoms and
suffer adverse effects of oral corticosteroids (OCS), including disturbed mood and physical …

Background Guidelines on COPD diagnosis and management encourage primary care
physicians to detect the disease at an early stage and to treat patients according to their …

Background Evidence for management of asthma comes from closely monitored efficacy
trials done in highly selected patient groups. There is a need for randomised trials that are …